The DOI matches its Crossref record; 550 of the 550 references it cites were found in a registry or an index.
Organic Cation Transporters in Health and Disease
Abstract
The organic cation transporters (OCTs) OCT1, OCT2, OCT3, novel OCT (OCTN)1, OCTN2, multidrug and toxin exclusion (MATE)1, and MATE kidney-specific 2 are polyspecific transporters exhibiting broadly overlapping substrate selectivities. They transport organic cations, zwitterions, and some uncharged compounds and operate as facilitated diffusion systems and/or antiporters. OCTs are critically involved in intestinal absorption, hepatic uptake, and renal excretion of hydrophilic drugs. They modulate the distribution of endogenous compounds such as thiamine, L-carnitine, and neurotransmitters. Sites of expression and functions of OCTs have important impact on energy metabolism, pharmacokinetics, and toxicity of drugs, and on drug–drug interactions. In this work, an overview about the human OCTs is presented. Functional properties of human OCTs, including identified substrates and inhibitors of the individual transporters, are described. Sites of expression are compiled, and data on regulation of OCTs are presented. In addition, genetic variations of OCTs are listed, and data on their impact on transport, drug treatment, and diseases are reported. Moreover, recent data are summarized that indicate complex drug–drug interaction at OCTs, such as allosteric high-affinity inhibition of transport and substrate dependence of inhibitor efficacies. A hypothesis about the molecular mechanism of polyspecific substrate recognition by OCTs is presented that is based on functional studies and mutagenesis experiments in OCT1 and OCT2. This hypothesis provides a framework to imagine how observed complex drug–drug interactions at OCTs arise. Finally, preclinical in vitro tests that are performed by pharmaceutical companies to identify interaction of novel drugs with OCTs are discussed. Optimized experimental procedures are proposed that allow a gapless detection of inhibitory and transported drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 550
The Role of the Mammalian Copper Transporter 1 in the Cellular Accumulation of Platinum-Based Drugs
Larson, C. A., Blair, B. G., Safaei, R., & Howell, S. B. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.052381 · Cited by 182
Yonezawa, A., Masuda, S., Nishihara, K., Yano, I., Katsura, T., & Inui, K.-I. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.020 · Cited by 180
Kim, R. B., Morse, B. L., Djurdjev, O., Tang, M., Muirhead, N., Barrett, B., Holmes, D. T., Madore, F., Clase, C. M., Rigatto, C., et al. (2016) · Kidney International · doi:10.1016/j.kint.2016.01.014 · Cited by 179 · cited 1×
“High plasma TMAO concentrations have been associated with development of chronic kidney and cardiovascular diseases (Brown and Hazen, 2014; Tang et al., 2015; Kim et al., 2016).”
BackgroundThe role of transporters in drug interactions
Endres, C. J., Hsiao, P., Chung, F. S., & Unadkat, J. D. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.11.002 · Cited by 179
Koizumi, A., Nozaki, J.-I., Ohura, T., TsuyoshiKayo, Wada, Y., Nezu, J.-I., Ohashi, R., Tamai, I., Shoji, Y., Takada, G., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.12.2247 · Cited by 179
Tissue Distribution of Human Monoamine Oxidase A and B mRNA
Grimsby, J., Lan, N. C., Neve, R., Chen, K., & Shih, J. C. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb03121.x · Cited by 178
Zhang, L., Schaner, M. E., & Giacomini, K. M. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37595-0 · Cited by 176
Sugar binding induces an outward facing conformation of LacY
Smirnova, I., Kasho, V., Choe, J.-Y., Altenbach, C., Hubbell, W. L., & Kaback, H. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708258104 · Cited by 176
Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2
Sprowl, J. A., Ciarimboli, G., Lancaster, C. S., Giovinazzo, H., Gibson, A. A., Du, G., Janke, L. J., Cavaletti, G., Shields, A. F., & Sparreboom, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305321110 · Cited by 175
Structural biology of solute carrier (SLC) membrane transport proteins
Bai, X., Moraes, T. F., & Reithmeier, R. A. F. (2017) · Molecular Membrane Biology · doi:10.1080/09687688.2018.1448123 · Cited by 175
Measurement of the renal clearance of drugs.
Tucker, G. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb01304.x · Cited by 174
Kantarjian, H. M., Cortes, J. E., O'Brien, S., Luthra, R., Giles, F., Verstovsek, S., Faderl, S., Thomas, D., Garcia-Manero, G., Rios, M. B., et al. (2004) · Blood · doi:10.1182/blood-2004-02-0711 · Cited by 173
Choline : an essential nutrient of humans
Zeisel, S. H. (2000) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/fayy-y290 · Cited by 173
Baganz, N. L., Horton, R. E., Calderon, A. S., Owens, W. A., Munn, J. L., Watts, L. T., Koldzic-Zivanovic, N., Jeske, N. A., Koek, W., Toney, G. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800466105 · Cited by 172
Tsuda, M., Terada, T., Mizuno, T., Katsura, T., Shimakura, J., & Inui, K.-I. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056242 · Cited by 172
Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney
Wu, X., Huang, W., Ganapathy, M. E., Wang, H., Kekuda, R., Conway, S. J., Leibach, F. H., & Ganapathy, V. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.3.f449 · Cited by 171
Tahara, H., Kusuhara, H., Endou, H., Koepsell, H., Imaoka, T., Fuse, E., & Sugiyama, Y. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088104 · Cited by 171
Self-citationRace and Unequal Burden of Perioperative Pain and Opioid Related Adverse Effects in Children
Sadhasivam, S., Chidambaran, V., Ngamprasertwong, P., Esslinger, H. R., Prows, C., Zhang, X., Martin, L. J., & McAuliffe, J. (2012) · Pediatrics · doi:10.1542/peds.2011-2607 · Cited by 170
Takano, M., Inui, K.-I., Okano, T., Saito, H., & Hori, R. (1984) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(84)90556-x · Cited by 170
Kido, Y., Matsson, P., & Giacomini, K. M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2001629 · Cited by 169
Tissue Distribution and Renal Developmental Changes in Rat Organic Cation Transporter mRNA levels
Slitt, A. L., Cherrington, N. J., Hartley, D. P., Leazer, T. M., & Klaassen, C. D. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.2.212 · Cited by 169
Interaction of Cisplatin with the Human Organic Cation Transporter 2
Filipski, K. K., Loos, W. J., Verweij, J., & Sparreboom, A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4793 · Cited by 169
Alcorn, J., Lu, X., Moscow, J. A., & McNamara, P. J. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.038315 · Cited by 165
Choudhuri, S., Cherrington, N. J., Li, N., & Klaassen, C. D. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.11.1337 · Cited by 164
A Common 5′-UTR Variant in MATE2-K Is Associated With Poor Response to Metformin
Choi, J. H., Yee, S. W., Ramirez, A. H., Morrissey, K. M., Jang, G. H., Joski, P. J., Mefford, J., Hesselson, S., Schlessinger, A., Jenkins, G. P., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.165 · Cited by 163
Proximal Tubular Secretion of Creatinine by Organic Cation Transporter OCT2 in Cancer Patients
Ciarimboli, G., Lancaster, C. S., Schlatter, E., Franke, R. M., Sprowl, J. A., Pavenstädt, H., Massmann, V., Guckel, D., Mathijssen, R. H. J., Yang, W., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2503 · Cited by 163
Yasui‐Furukori, N., Uno, T., SUGAWARA, K., & TATEISHI, T. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.08.026 · Cited by 162
Monks, N. R., Liu, S., Xu, Y., Yu, H., Bendelow, A. S., & Moscow, J. A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0500 · Cited by 161
Kamiyama, Y., Matsubara, T., Yoshinari, K., Nagata, K., Kamimura, H., & Yamazoe, Y. (2007) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.22.287 · Cited by 159
Sweet, D. H., Miller, D. S., & Pritchard, J. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108472200 · Cited by 158
Samimi, G., Katano, K., Holzer, A. K., Safaei, R., & Howell, S. B. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.25 · Cited by 158
Choline metabolism-based molecular diagnosis of cancer: an update
Glunde, K., Penet, M.-F., Jiang, L., Jacobs, M. A., & Bhujwalla, Z. M. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1039515 · Cited by 158
Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters
Okabe, M., Szakács, G., Reimers, M. A., Suzuki, T., Hall, M. D., Abe, T., Weinstein, J. N., & Gottesman, M. M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0539 · Cited by 158
Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population
Cui, R., Okada, Y., Jang, S. G., Ku, J. L., Park, J. G., Kamatani, Y., Hosono, N., Tsunoda, T., Kumar, V., Tanikawa, C., et al. (2011) · Gut · doi:10.1136/gut.2010.215947 · Cited by 156
Zhang, T., Xiang, C. D., Gale, D. C., Carreiro, S. T., Wu, E. Y., & Zhang, E. Y. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021121 · Cited by 156
Tzvetkov, M. V., Saadatmand, A. R., Bokelmann, K., Meineke, I., Kaiser, R., & Brockmöller, J. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.75 · Cited by 154
Tamai, I., China, K., Sai, Y., Kobayashi, D., Nezu, J., Kawahara, E., & Tsuji, A. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00328-5 · Cited by 153
Tang, N. L. S., Ganapathy, V., Wu, X., Hui, J., Seth, P., Yuen, P. M. P., Fok, T. F., & Hjelm, N. M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.655 · Cited by 153
Yee, S. W., Brackman, D. J., Ennis, E. A., Sugiyama, Y., Kamdem, L. K., Blanchard, R. L., Galetin, A., Zhang, L., & Giacomini, K. M. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1098 · Cited by 153
Jung, N., Lehmann, C., RUBBERT, A., Knispel, M., Hartmann, P., van Lunzen, J., Stellbrink, H., Faetkenheuer, G., & Taubert, D. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.020826 · Cited by 152
Bacq, A., Balasse, L., Biała, G., Guiard, B. P., Gardier, A. M., Schinkel, A. H., Louis, F., Vialou, V., Martres, M., Chevarin, C., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.87 · Cited by 150
Molecular Pharmacology of Organic Cation Transporters in Kidney
Koepsell, H., Gorboulev, V., & Arndt, P. (1999) · The Journal of Membrane Biology · doi:10.1007/s002329900475 · Cited by 149
Self-citationSchaeffeler, E., Hellerbrand, C., Nies, A. T., Winter, S., Kruck, S., Hofmann, U., van der Kuip, H., Zanger, U. M., Koepsell, H., & Schwab, M. G. (2011) · Genome Medicine · doi:10.1186/gm298 · Cited by 149
Self-citationTzvetkov, M. V., Saadatmand, A. R., Lötsch, J., Tegeder, I., Stingl, J., & Brockmöller, J. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.56 · Cited by 147
Wittwer, M., Zur, A. A., Khuri, N., Kido, Y., Kosaka, A. H., Zhang, X., Morrissey, K. M., Šali, A., Huang, Y., & Giacomini, K. M. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301302s · Cited by 147
Gröer, C., Brück, S., Lai, Y., Paulick, A., Busemann, A., Heidecke, C.-D., Siegmund, W., & Oswald, S. (2013) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2013.07.031 · Cited by 146
Wogan, G. N., Kensler, T. W., & Groopman, J. D. (2011) · Food Additives & Contaminants Part A · doi:10.1080/19440049.2011.563370 · Cited by 146
Herráez, E., Lozano, E., Macı́as, R. I. R., Vaquero, J., Bujanda, L., Bañales, J. M., Marı́n, J. J. G., & Briz, Ó. (2013) · Hepatology · doi:10.1002/hep.26425 · Cited by 143
Gasser, P. J., Lowry, C. A., & Orchinik, M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0570-06.2006 · Cited by 142
Profiling Solute Carrier Transporters in the Human Blood–Brain Barrier
Geier, E. G., Chen, E. C., Webb, A., Papp, A. C., Yee, S. W., Sadée, W., & Giacomini, K. M. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.175 · Cited by 142
Droździk, M., Busch, D., Łapczuk-Romańska, J., Müller, J., Ostrowski, M., Kurzawski, M., & Oswald, S. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1301 · Cited by 142
A phosphotyrosine switch regulates organic cation transporters
Sprowl, J. A., Ong, S. S., Gibson, A. A., Hu, S., Du, G., Lin, W., Li, L., Bharill, S., Ness, R. A., Stecuła, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms10880 · Cited by 140
Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response
Becker, M. L., Visser, L. E., van Schaik, R. H. N., Albert Hofman, D., Uitterlinden, A. G., & Stricker, B. H. C. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328333bb11 · Cited by 139
zu Schwabedissen, H. E. M., Verstuyft, C., Kroemer, H. K., Becquemont, L., & Kim, R. B. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00431.2009 · Cited by 138
Newman, W. G., Gu, X., Wintle, R. F., Cescon, D. W., Yazdanpanah, M., Liu, X., Peltekova, V. D., Oene, M. V., Amos, C. I., & Siminovitch, K. A. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.056 · Cited by 137
The metabolism of tramadol by human liver microsomes
Paar, W. D., Frankus, P., & Dengler, H. J. (1992) · Journal of Molecular Medicine · doi:10.1007/bf00180294 · Cited by 137
Satriano, J. A., Matsufuji, S., Murakami, Y., Lortie, M. J., Schwartz, D., Kelly, C., Hayashi, S., & Blantz, R. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15313 · Cited by 137
Tarāsova, L., Kalniņa, I., Geldnere, K., Bumbure, A., Ritenberga, R., Ņikitina-Zaķe, L., Frīdmanis, D., Vaivade, I., Pīrāgs, V., & Kloviņš, J. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283561666 · Cited by 136
Jong, N. N., Nakanishi, T., Liu, J. J., Tamai, I., & McKeage, M. J. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.181297 · Cited by 136
Minuesa, G., Volk, C., Molina‐Arcas, M., Gorboulev, V., Erkizia, I., Arndt, P., Clotet, B., Pastor‐Anglada, M., Koepsell, H., & Martínez‐Picado, J. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146225 · Cited by 136
Self-citationArndt, P., Volk, C., Gorboulev, V., Budiman, T., Popp, C., Ulzheimer-Teuber, I., Akhoundova, A., Koppatz, S., Bamberg, E., Nagel, G., et al. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.3.f454 · Cited by 136
Self-citationHacker, K., Maas, R., Kornhuber, J., Fromm, M. F., & Zolk, O. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136451 · Cited by 135
Tj, U., Brown, C., Castro, R. A., Shah, N. D., Mercer, R., Huang, Y. L., Brett, C., Burchard, E. G., & Giacomini, K. M. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100271 · Cited by 133
Functional characterization of the human high‐affinity choline transporter1
Okuda, T., & Haga, T. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02134-7 · Cited by 130
Eudy, J. D., Spiegelstein, O., Barber, R. C., Wlodarczyk, B. J., Talbot, J. T., & Finnell, R. H. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3112 · Cited by 129
Expression and functional contribution of hTHTR-2 in thiamin absorption in human intestine
Said, H. M., Balamurugan, K., Subramanian, V. S., & Marchant, J. S. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00361.2003 · Cited by 127
Creatine synthesis: production of guanidinoacetate by the rat and human kidney in vivo
Edison, E. E., Brosnan, M. E., Meyer, C., & Brosnan, J. T. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00356.2007 · Cited by 127
Han, T. K., Proctor, W. R., Costales, C., Cai, H., Everett, R., & Thakker, D. R. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.220350 · Cited by 127
Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer
Chang, Q., Zhang, Y., Beezhold, K., Bhatia, D., Zhao, H., Chen, J., Castranova, V., Shi, X., & Chen, F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.037 · Cited by 127
Kumar, H., Kasho, V. N., Смирнова, И. Н., Finer-Moore, J. S., Kaback, H. R., & Stroud, R. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324141111 · Cited by 126
Functional and pharmacological characterization of human Na+-carnitine cotransporter hOCTN2
Wagner, C. A., Lükewille, U., Kaltenbach, S., Moschén, I., Bröer, A., Risler, T., Bröer, S., & Lang, F. J. W. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.3.f584 · Cited by 125
Gasser, P. J., Orchinik, M., Raju, I., & Lowry, C. A. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21921 · Cited by 125
Interaction of Oral Antidiabetic Drugs With Hepatic Uptake Transporters
Bachmakov, I., Glaeser, H., Fromm, M. F., & König, J. (2008) · Diabetes · doi:10.2337/db07-1515 · Cited by 125
Nies, A. T., Herrmann, E., Brom, M., & KEPPLER, D. O. R. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0219-x · Cited by 124
Functional Analysis of Organic Cation Transporter 3 Expressed in Human Placenta
Sata, R., Ohtani, H., Tsujimoto, M., Murakami, H., Koyabu, N., Nakamura, T., Uchiumi, T., Kuwano, M., Nagata, H., Tsukimori, K., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.086827 · Cited by 123
Burger, H., Zoumaro-Djayoon, A. D., Boersma, A., Helleman, J., Berns, E., Mathijssen, R. H. J., Loos, W., & Wiemer, E. A. C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00569.x · Cited by 122
Lamhonwah, A., Olpin, S. E., Pollitt, R. J., Vianey‐Saban, C., Divry, P., Guffon, N., BESLEY, G. T. N., Onizuka, R., Meirleir, L. J. D., Cvitanović-Šojat, L., et al. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10585 · Cited by 121
Abemaciclib Inhibits Renal Tubular Secretion Without Changing Glomerular Filtration Rate
Chappell, J. C., Turner, P. K., Pak, Y. A., Bacon, J. A., Chiang, A. Y., Royalty, J. E., Hall, S. D., Kulanthaivel, P., & Bonventre, J. V. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1296 · Cited by 121
Heise, M., Lautem, A., Knapstein, J., Schattenberg, J., Hoppe-Lotichius, M., Foltys, D., Weiler, N., Zimmermann, A., Schad, A., Gründemann, D., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-109 · Cited by 120
Uptake of Cardiovascular Drugs Into the Human Heart
Grube, M., zu Schwabedissen, H. E. M., Präger, D., Haney, J., Möritz, K.-U., Meissner, K., Rosskopf, D., Eckel, L., Böhm, M., Jedlitschky, G., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.586107 · Cited by 118
Mehrens, T., LELLECK, S., CEDILLA]ETINKAYA, I. C., KNOLLMANN, M., Hohage, H., Gorboulev, V., Boknı́k, P., Koepsell, H., & Schlatter, E. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1171216 · Cited by 117
Self-citationElectrophysiology of the Circumventricular Organs
Ferguson, A. V., & Bains, J. S. (1996) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1996.0012 · Cited by 116
Zolk, O., Solbach, T. F., König, J., et al. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0369-5 · Cited by 116
Moriyama, Y., Hiasa, M., Matsumoto, T., & Omote, H. (2008) · Xenobiotica · doi:10.1080/00498250701883753 · Cited by 116
Seitz, T., Stalmann, R., Dalila, N., Chen, J., Pojar, S., Pereira, J. N. S., Krätzner, R., Brockmöller, J., & Tzvetkov, M. V. (2015) · Genome Medicine · doi:10.1186/s13073-015-0172-0 · Cited by 115
Verhaagh, S., Schweifer, N., Barlow, D. P., & Zwart, R. (1999) · Genomics · doi:10.1006/geno.1998.5639 · Cited by 115
Evidence for association of OCTN genes and IBD5 with ulcerative colitis
Waller, S., Tremelling, M., Bredin, F., Godfrey, L., Howson, J. M. M., & Parkes, M. (2005) · Gut · doi:10.1136/gut.2005.084574 · Cited by 115
Altered aminergic neurotransmission in the brain of organic cation transporter 3‐deficient mice
Vialou, V., Balasse, L., Callebert, J., Launay, J., Giros, B., & Gautron, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05506.x · Cited by 114
Markova, N. G., Karaman‐Jurukovska, N., Dong, K. K., Damaghi, N., Smiles, K. A., & Yarosh, D. B. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.01.021 · Cited by 113
Involvement of OCTN1 (SLC22A4) in pH-Dependent Transport of Organic Cations
Tamai, I., Nakanishi, T., Kobayashi, D., China, K., Kosugi, Y., Nezu, J., Sai, Y., & Tsuji, A. (2003) · Molecular Pharmaceutics · doi:10.1021/mp0340082 · Cited by 113
Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta‐Analysis
Dujić, T., Zhou, K., Yee, S. W., van Leeuwen, N., de Keyser, C., Javorský, M., Goswami, S., Zaharenko, L., Christensen, M. M. H., Out, M., et al. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.567 · Cited by 113
Membrane Localization of the Electrogenic Cation Transporter rOCT1 in Rat Liver
Meyer‐Wentrup, F. A. G., Karbach, U., Gorboulev, V., Arndt, P., & Koepsell, H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9034 · Cited by 112
Self-citationThe choline transporter-like family SLC44: Properties and roles in human diseases
Traiffort, É., O’Regan, S., & Ruat, M. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.011 · Cited by 111
Influence of Molecular Structure on Substrate Binding to the Human Organic Cation Transporter, hOCT1
Bednarczyk, D., Ekins, S., Wikel, J. H., & Wright, S. H. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.3.489 · Cited by 111
Epithelial Organic Cation Transporters Ensure pH-Dependent Drug Absorption in the Airway
Horváth, G., Schmid, N., Fragoso, M. A., Schmid, A., Conner, G. E., Salathe, M. A., & Wanner, A. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0230oc · Cited by 111
Organic anion and cation transporters occur in pairs of similar and similarly expressed genes
Eraly, S. A., Hamilton, B. A., & Nigám, S. K. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02853-x · Cited by 110
Gründemann, D., Hahne, C., Berkels, R., & Schömig, E. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044404 · Cited by 109
Bourdet, D. L., Pritchard, J. B., & Thakker, D. R. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.091223 · Cited by 109
Organic Cation Transporter 3 (Slc22a3) Is Implicated in Salt-Intake Regulation
Vialou, V., Amphoux, A., Zwart, R., Giros, B., & Gautron, S. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5147-03.2004 · Cited by 109
Hiasa, M., Matsumoto, T., Komatsu, T., & Moriyama, Y. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00090.2006 · Cited by 109
Hendrickx, R., Johansson, J. G., Lohmann, C., Jenvert, R.-M., Blomgren, A., Börjesson, L., & Gustavsson, L. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400966v · Cited by 109
Higgins, J. W., Bedwell, D. W., & Zamek‐Gliszczynski, M. J. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.044875 · Cited by 108
Kang, H., Song, I., Shin, H. J., Kim, W., Lee, C., Shim, J.-C., Zhou, H., Lee, S. S., & Shin, J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.013581 · Cited by 108
Ito, S., Kusuhara, H., Kumagai, Y., Moriyama, Y., Inoue, K., Kondo, T., Nakayama, H., Horita, S., Tanabe, K., Yuasa, H., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.138 · Cited by 108
Russell, R. K., Drummond, H. E., Nimmo, E. R., Anderson, N. H., Noble, C. L., Wilson, D. C., Gillett, P. M., McGrogan, P., Hassan, K., Weaver, L. T., et al. (2006) · Gut · doi:10.1136/gut.2005.082107 · Cited by 108
Imamura, Y., Murayama, N., Okudaira, N., Kurihara, A., Okazaki, O., Izumi, T., Inoue, K., Yuasa, H., Kusuhara, H., & Sugiyama, Y. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.232 · Cited by 108
Ciarimboli, G., Holle, S. K., Vollenbröcker, B., et al. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100329u · Cited by 107
CARD15 and HLA DRB1 Alleles Influence Susceptibility and Disease Localization in Crohn's Disease
Newman, W. G., Silverberg, M. S., Gu, X., Zhang, Q., Lázaro, A. M. P., Steinhart, A. H., Greenberg, G. R., Griffiths, A. M., McLeod, R. S., Cohen, Z., et al. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04038.x · Cited by 107
Chen, E. C., Liang, X., Yee, S. W., Geier, E. G., STOCKER, S. L., Chen, L., & Giacomini, K. M. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.096776 · Cited by 107
Substrate-Dependent Ligand Inhibition of the Human Organic Cation Transporter OCT2
Belzer, M., Morales, M. N., Jagadish, B., Mash, E. A., & Wright, S. H. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.203257 · Cited by 107
Schmitt, A., Mössner, R., Gossmann, A., Fischer, I., Gorboulev, V., Murphy, D., Koepsell, H., & Lesch, K. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10521 · Cited by 106
Self-citationPereira, J. N. S., Tadjerpisheh, S., Abed, M. A., Saadatmand, A. R., Weksler, B. B., Romero, I. A., Couraud, P., Brockmöller, J., & Tzvetkov, M. V. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9649-9 · Cited by 106
Sakata, T., Anzai, N., Shin, H. J., Noshiro, R., Hirata, T., Yokoyama, H., Kanai, Y., & Endou, H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.175 · Cited by 106
Dopamine-derived endogenous N-methyl-(R)-salsolinol
Naoi, M., Maruyama, W., Akao, Y., & Yi, H. L. (2002) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(02)00211-8 · Cited by 105
Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin
Liu, Y., Zheng, X., Yu, Q., Wang, H., Tan, F.-Q., Zhu, Q., Yuan, L., Jiang, H., Yu, L., & Zeng, S. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf3124 · Cited by 105
Matsushima, S., Maeda, K., Inoue, K., Ohta, K., Yuasa, H., Kondo, T., Nakayama, H., Horita, S., Kusuhara, H., & Sugiyama, Y. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023911 · Cited by 104
Molecular Cloning and Characterization of High-Affinity Carnitine Transporter from Rat Intestine
Sekine, T., Kusuhara, H., Utsunomiya‐Tate, N., Tsuda, M., Sugiyama, Y., Kanai, Y., & Endou, H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9521 · Cited by 103
Han, T. K., Everett, R., Proctor, W. R., Ng, C. M., Costales, C., Brouwer, K. L. R., & Thakker, D. R. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.084517 · Cited by 103
Dresser, M. J., Gray, A. T., & Giacomini, K. M. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35400-x · Cited by 102
Nakamura, T., Nakanishi, T., Haruta, T., Shirasaka, Y., Keogh, J. P., & Tamai, I. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900206j · Cited by 102
Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function
Chen, Y., Teranishi, K. S., Li, S., Yee, S. W., Hesselson, S., Stryke, D., Johns, S. J., Ferrin, T. E., Kwok, P., & Giacomini, K. M. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2008.19 · Cited by 102
Traiffort, É., Ruat, M., O'Regan, S., & Meunier, F.-M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02962.x · Cited by 101
Sundelin, E. I. O., Gormsen, L. C., Jensen, J. T., Vendelbo, M. H., Jakobsen, S., Munk, O. L., Christensen, M., Brøsen, K., Frøkiær, J., & Jessen, N. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.701 · Cited by 101
OCT1 expression in adipocytes could contribute to increased metformin action in obese subjects
Moreno-Navarrete, J. M., Ortega, F. J., Rodríguez-Hermosa, J.-I., Sabater, M., Pardo, G., Ricart, W., & Fernández-Real, J. M. (2011) · Diabetes · doi:10.2337/db10-0805 · Cited by 100
Matthaei, J., Kuron, D., Faltraco, F., Knoch, T., Pereira, J. N. S., Abed, M. A., Prukop, T., Brockmöller, J., & Tzvetkov, M. V. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.317 · Cited by 100
Localization of monoamine oxidases in human peripheral tissues
Saura, J., Nadal, E., van den Berg, B., Vila, M., Bombí, J. A., & Mahy, N. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00459-6 · Cited by 99
OCT1 Genetic Variants Influence the Pharmacokinetics of Morphine in Children
Fukuda, T., Chidambaran, V., Mizuno, T., Venkatasubramanian, R., Ngamprasertwong, P., Olbrecht, V. A., Esslinger, H. R., Vinks, A. A. T. M. M., & Sadhasivam, S. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.94 · Cited by 99
Trimethylamine: Metabolic, Pharmacokinetic and Safety Aspects
Bain, M., Fornasini, G., & Evans, A. (2005) · Current Drug Metabolism · doi:10.2174/1389200054021807 · Cited by 98
Yokoo, S., Masuda, S., Yonezawa, A., Terada, T., Katsura, T., & Inui, K. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023168 · Cited by 98
Transport of Dicationic Drugs Pentamidine and Furamidine by Human Organic Cation Transporters
Ming, X., Ju, W., Wu, H., Tidwell, R. R., Hall, J. E., & Thakker, D. R. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024083 · Cited by 97
A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol
Bremner, P. R., Woodman, K., Burgess, C., Crane, J., Purdie, G., Pearce, N. E., & Beasley, R. W. (1993) · European Respiratory Journal · doi:10.1183/09031936.93.06020204 · Cited by 97
David, D. J. P., Bourin, M., Jego, G., Przybylski, C., Jolliet, P., & Gardier, A. M. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705538 · Cited by 96
Ethnicity influences morphine pharmacokinetics and pharmacodynamics
Cepeda, M. S., Farrar, J. T., Roa, J. H., Boston, R., Meng, Q. C., Ruiz, F., Carr, D. B., & Strom, B. L. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(01)51508-8 · Cited by 96
Iwata, K., Aizawa, K., Kamitsu, S., Jingami, S., Fukunaga, E., Yoshida, M., Yoshimura, M., Hamada, A., & Saito, H. (2012) · Clinical and Experimental Nephrology · doi:10.1007/s10157-012-0638-y · Cited by 95
Chen, L., Takizawa, M., Chen, E., Schlessinger, A., Siegenthaler, J. A., Choi, J. H., Sali, A., Kubo, M., Nakamura, S., Iwamoto, Y., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.170159 · Cited by 95
van Montfoort, J. E., Müller, M. M., Groothuis, G. M. M., Meijer, D. K. F., Koepsell, H., & Meier, P. J. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29357-5 · Cited by 94
Self-citationAoki, M., Terada, T., Kajiwara, M., Ogasawara, K., Ikai, I., Ogawa, O., Katsura, T., & Inui, K. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90257.2008 · Cited by 94
The Human Organic Cation Transporter-1 Gene Is Transactivated by Hepatocyte Nuclear Factor-4α
Saborowski, M., Kullak-Ublick, G. A., & Eloranta, J. J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.099929 · Cited by 94
Bottalico, B., Larsson, I., Brodszki, J., Hernandez-Andrade, E., Casslén, B., Marsál, K., & Hansson, S. R. (2004) · Placenta · doi:10.1016/j.placenta.2003.10.017 · Cited by 94
Sandoval, P. J., Zorn, K. M., Clark, A. M., Ekins, S., & Wright, S. H. (2018) · Molecular Pharmacology · doi:10.1124/mol.117.111443 · Cited by 94
Feng, B., Obach, R., Burstein, A., Clark, D., de Morais, S., & Faessel, H. M. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100405 · Cited by 93
Dresser, M. J., Xiao, G., Leabman, M. K., Gray, A. T., & Giacomini, K. M. (2002) · Pharmaceutical Research · doi:10.1023/a:1019870831174 · Cited by 92
Mechanism of Electrogenic Cation Transport by the Cloned Organic Cation Transporter 2 from Rat
Budiman, T., Bamberg, E., Koepsell, H., & Nagel, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004645200 · Cited by 92
Self-citationGenetic and epigenetic regulation of the organic cation transporter 3, SLC22A3
Chen, L., Hong, C., Chen, E. C., Yee, S. W., Xu, L., Almof, E. U., Wen, C., Fujii, K., Johns, S. J., Stryke, D., et al. (2012) · The Pharmacogenomics Journal · doi:10.1038/tpj.2011.60 · Cited by 92
PDZK1 Directly Regulates the Function of Organic Cation/Carnitine Transporter OCTN2
Kato, Y., Sai, Y., Yoshida, K., Watanabe, C., Hirata, T., & Tsuji, A. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.002212 · Cited by 92
Kato, Y., Sugiura, M., Sugiura, T., Wakayama, T., Kubo, Y., Kobayashi, D., Sai, Y., Tamai, I., Iseki, S., & Tsuji, A. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.024158 · Cited by 92
Inazu, M., Takeda, H., & Matsumiya, T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01566.x · Cited by 91
Gorboulev, V., Shatskaya, N. V., Volk, C., & Koepsell, H. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008821 · Cited by 91
Self-citationIdentification and Characterization of Trimethylamine-N-oxide Uptake and Efflux Transporters
Teft, W. A., Morse, B. L., Leake, B. F., Wilson, A. S., Mansell, S. E., Hegele, R. A., Ho, R. H., & Kim, R. B. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00937 · Cited by 91
Regulation of human organic cation transporter hOCT2 by PKA, PI3K, and calmodulin-dependent kinases
Çetinkaya, I., Ciarimboli, G., Yalçinkaya, G., Mehrens, T., Velić, A., Hirsch, J. R., Gorboulev, V., Koepsell, H., & Schlatter, E. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00251.2002 · Cited by 90
Self-citationSilverberg, M. S., Duerr, R. H., Brant, S. R., Bromfield, G. P., Datta, L. W., Jani, N. D., Kane, S. V., Rotter, J. I., Schumm, L. P., Steinhart, A. H., et al. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201756 · Cited by 90
Astorga, B., Ekins, S., Morales, M. N., & Wright, S. H. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.191577 · Cited by 90
Ahlin, G., Chen, L., Lazorova, L., Chen, Y., Ianculescu, A. G., Davis, R. L., Giacomini, K. M., & Artursson, P. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.54 · Cited by 89
Genes, Microbes, and T Cells — New Therapeutic Targets in Crohn's Disease
Elson, C. O. (2002) · New England Journal of Medicine · doi:10.1056/nejm200202213460812 · Cited by 89
Pochini, L., Galluccio, M., Scalise, M., Console, L., & Indiveri, C. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218812821 · Cited by 89
Lee, N., Duan, H., Hébert, M. F., Liang, C., Rice, K. M., & Wang, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.570564 · Cited by 88
Characterization of the enzyme responsible for the metabolism of sumatriptan in human liver
Dixon, C. M., Park, G. R., & Tarbit, M. H. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90397-2 · Cited by 87
Regulation of the human organic cation transporter hOCT1
Ciarimboli, G., Struwe, K., Arndt, P., Gorboulev, V., Koepsell, H., Schlatter, E., & Hirsch, J. R. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20081 · Cited by 87
Self-citationSeth, P., Wu, X., Huang, W. Y., Leibach, F. H., & Ganapathy, V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33388 · Cited by 85
Ballestero, M. R., Monte, M. J., Briz, Ó., Jimenez, F., Martin, F. G.-S., & Marı́n, J. J. G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.007 · Cited by 84
Conformational Change in an MFS Protein: MD Simulations of LacY
Holyoake, J., & Sansom, M. S. P. (2007) · Structure · doi:10.1016/j.str.2007.06.004 · Cited by 84
Volk, C., Gorboulev, V., Budiman, T., Nagel, G., & Koepsell, H. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.5.1037 · Cited by 82
Self-citationYoon, H., Cho, H., Yoo, H., Kim, S., & Lee, Y. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9460-z · Cited by 82
Role of organic cation transporters (OCTs) in the brain
Couroussé, T., & Gautron, S. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.09.008 · Cited by 81
Loss of multidrug and toxin extrusion 1 (MATE1) is associated with metformin‐induced lactic acidosis
Toyama, K., Yonezawa, A., Masuda, S., Osawa, R., Hosokawa, M., Fujimoto, S., Inagaki, N., Inui, K., & Katsura, T. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01853.x · Cited by 80
Metaorganismal nutrient metabolism as a basis of cardiovascular disease
Brown, J. M., & Hazen, S. L. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000036 · Cited by 80
Grigat, S., Fork, C., Bach, M., Gölz, S., Geerts, A., Schömig, E., & Gründemann, D. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023929 · Cited by 80
Jouan, E., Vée, M. L., Denizot, C., Violante, G. D., & Fardel, O. (2012) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2012.01071.x · Cited by 79
Keller, T., Egenberger, B., Gorboulev, V., Bernhard, F., Uzelac, Ž., Gorbunov, D., Wirth, C., Koppatz, S., Dötsch, V., Hunte, C., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.289330 · Cited by 79
Self-citationChristensen, M. M. H., Pedersen, R. S., Stage, T. B., Brasch‐Andersen, C., Nielsen, F., Damkier, P., Beck‐Nielsen, H., & Brøsen, K. (2013) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328364a57d · Cited by 78
Transport mechanisms governing serotonin clearance in vivo revealed by high-speed chronoamperometry
Daws, L. C., Montañez, S., Owens, W. A., Gould, G. G., Frazer, A., Toney, G. M., & Gerhardt, G. A. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2004.09.011 · Cited by 78
Ahmadimoghaddam, D., Zemánková, L., Nachtigal, P., Doleželová, E., Neumanova, Z., Červený, L., Čečková, M., Kacerovský, M., Mičuda, S., & Štaud, F. (2013) · Biology of Reproduction · doi:10.1095/biolreprod.112.105064 · Cited by 78
Nakamichi, N., Shima, H., Asano, S., Ishimoto, T., Sugiura, T., Matsubara, K., Kusuhara, H., Sugiyama, Y., Sai, Y., Miyamoto, K., et al. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23595 · Cited by 77
The lactose transport protein is a cooperative dimer with two sugar translocation pathways
Veenhoff, L. M., Heuberger, E. H. M. L., & Poolman, B. (2001) · The EMBO Journal · doi:10.1093/emboj/20.12.3056 · Cited by 77
Zhang, L., Gorset, W., Washington, C. B., Blaschke, T. F., Kroetz, D. L., & Giacomini, K. M. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15369-x · Cited by 77
Dudley, A. J., Bleasby, K., & Brown, C. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703518 · Cited by 75
Primary Carnitine Deficiency and Newborn Screening for Disorders of the Carnitine Cycle
Longo, N. (2016) · Annals of Nutrition and Metabolism · doi:10.1159/000448321 · Cited by 75
Functional and molecular studies in primary carnitine deficiency
Frigeni, M., Balakrishnan, B., Yin, X., Calderon, F. R. O., Mao, R., Pasquali, M., & Longo, N. (2017) · Human Mutation · doi:10.1002/humu.23315 · Cited by 75
Grube, M., Ameling, S., Noutsias, M., Köck, K., Triebel, I., Bonitz, K., Meissner, K., Jedlitschky, G., Herda, L. R., Reinthaler, M., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.02.020 · Cited by 74
The two human organic cation transporter genes SLC22A1 and SLC22A2 are located on chromosome 6q26
Koehler, M. R., Wissinger, B., Gorboulev, V., Koepsell, H., & Schmid, M. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000134720 · Cited by 74
Self-citationCardiomyopathy and carnitine deficiency
Filippo, C. A. D. S., Taylor, M. R. G., Mestroni, L., Botto, L. D., & Longo, N. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.02.002 · Cited by 74
Saadatmand, A. R., Tadjerpisheh, S., Brockmöller, J., & Tzvetkov, M. V. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.032 · Cited by 73
Molecular Mechanism of Renal Tubular Secretion of the Antimalarial Drug Chloroquine
Müller, F., König, J., Glaeser, H., Schmidt, I., Zolk, O., Fromm, M. F., & Maas, R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01835-10 · Cited by 73
Verapamil decreases the glucose‐lowering effect of metformin in healthy volunteers
Cho, S. K., Kim, C. O., Park, E. S., & Chung, J. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12476 · Cited by 72
Grigat, S., Harlfinger, S., Pal, S., Striebinger, R., Golz, S., Geerts, A., Lazar, A., Schömig, E., & Gründemann, D. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.04.015 · Cited by 72
Nies, A. T., Damme, K., Kruck, S., Schaeffeler, E., & Schwab, M. G. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1728-5 · Cited by 72
Tzvetkov, M. V., Matthaei, J., Pojar, S., Faltraco, F., Vogler, S., Prukop, T., Seitz, T., & Brockmöller, J. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.812 · Cited by 72
Zhang, X., Shirahatti, N. V., Mahadevan, D., & Wright, S. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506342200 · Cited by 71
Pochini, L., Scalise, M., Galluccio, M., Pani, G., Siminovitch, K. A., & Indiveri, C. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.12.014 · Cited by 71
Minuesa, G., Purcet, S., Erkizia, I., Molina‐Arcas, M., Bofill, M., Izquierdo‐Useros, N., Casado, F. J., Clotet, B., Pastor‐Anglada, M., & Martínez‐Picado, J. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.131482 · Cited by 70
Identification of two novel mutations in OCTN2 of three patients with systemic carnitine deficiency
Vaz, F. M., Scholte, H. R., Ruiter, J. P. N., Hussaarts-Odijk, L. M., Pereira, R. R., Schweitzer, S., de Klerk, J. B. C., Waterham, H. R., & Wanders, R. J. A. (1999) · Human Genetics · doi:10.1007/s004399900105 · Cited by 70
Selective Inhibition of Human Solute Carrier Transporters by Multikinase Inhibitors
Johnston, R. A., Rawling, T., Chan, T., Zhou, F., & Murray, M. T. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.059097 · Cited by 70
Characterization of regulatory mechanisms and states of human organic cation transporter 2
Biermann, J., Lang, D., Gorboulev, V., Koepsell, H., Sinđić, A., Schröter, R., Žvirblienė, A., Pavenstädt, H. J., Schlatter, E., & Ciarimboli, G. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00622.2005 · Cited by 69
Self-citationSugiura, T., Kato, S., Shimizu, T., Wakayama, T., Nakamichi, N., Kubo, Y., Iwata, D., Suzuki, K., Soga, T., Asano, M., et al. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.032763 · Cited by 69
UhpT, the sugar phosphate antiporter of Escherichia coli, functions as a monomer.
Ambudkar, S. V., Anantharam, V., & Maloney, P. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38343-7 · Cited by 68
Laboratory diagnosis of defects of creatine biosynthesis and transport
Verhoeven‐Duif, N. M., Salomons, G. S., & Jakobs, C. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.04.022 · Cited by 68
Palmieri, O., Latiano, A., Valvano, R., Renata D'Incà, Vecchi, M. L., Sturniolo, G. C., Saibeni, S., Peyvandi, F., Bossa, F., Zagaria, C., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02780.x · Cited by 67
Ohashi, R., Tamai, I., Inano, A., Katsura, M., Sai, Y., Nezu, J., & Tsuji, A. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.036004 · Cited by 67
Brast, S., Grabner, A., Sučić, S., Sitte, H. H., Hermann, E., Pavenstädt, H. J., Schlatter, E., & Ciarimboli, G. (2011) · The FASEB Journal · doi:10.1096/fj.11-180679 · Cited by 67
Choline Transporters in Human Lung Adenocarcinoma: Expression and Functional Implications
Wang, T., Li, J., Chen, F., Zhao, Y., He, X., Wan, D., & Gu, J. (2007) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2007.00323.x · Cited by 66
Cited by
Structural basis of organic cation transporter-3 inhibition
Khanppnavar, B., Maier, J., Herborg, F., Gradisch, R., Lazzarin, E., Luethi, D., Yang, J.-W., Qi, C., Holy, M., Jäntsch, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34284-8 · Cited by 77
The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy
Puris, E., Fricker, G., & Gynther, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020364 · Cited by 58
Yue, Q., Leng, X., Xie, N., Zhang, Z., Yang, D., & Hoi, M. P. M. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70079 · Cited by 48
Metadata
- Authors
- Koepsell, H.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 72
- Issue
- 1
- Pages
- 253-319
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2994850615
- Cited by
- 297
- References
- 550
- FWCI
- 12.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.